Minding the London Stock Exchange’s Business
Independent and Fearless Financial Journalism Funded by Readers
Even a few of our detractors have now come around
The CEO of Microsaic Systems (MSYS) Glenn Tracey is “thrilled to report this transformational performance for the first half of 2021”. The shares have responded to the half-year results announcement to currently 0.22p, more than 12% lower! So what’s going on?…
“Microsaic Systems plc (MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce its unaudited interim results for the six months ended 30 June 2020 and an update on trading since the period end”. Encouraging then?…
“Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce its audited financial results for the year ended 31 December 2019”. The shares have currently responded to 0.80p – 20% lower!…
Previously writing on developer of mass spectrometry instruments Microsaic Systems (MSYS) it was with the company arguing “encouraged with the progress made in the first half” but the shares down to 1.15p. They have since fallen further and today a “Global collaboration agreement with Axcend Corp”…
“Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce its unaudited interim results for the six months ended 30 June 2019”. The shares have currently responded to 1.15p – er, more than 25% lower!...
An intra-day (11:20am) “Bioprocessing partnership update & trading update” from mass spectrometry instruments developer Microsaic Systems (MSYS). This firstly “confirms that trading in 2018 remains in line with the board's expectations” and then that phase two of the partnership “with a global partner in bioprocessing… has now been completed successfully, with a clear addressable market identified and positive feedback received from potential customers”. So why a 25% share price fall, towards 1p?...
